3 completed, 3 terminated. 4 Phase 1, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 3, Completed 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow John Sundy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Strategies for Enhancing Mucosal Immunity to Influenza Vaccine Fluzone - Mucosal Immunity | Early Phase 1 | Completed | John Sundy | 60 | 2011-04-01 | 2012-12-06 |
| Genetics of Asthma - Bronchoscopy Studies Endotoxin - lipopolysaccharide (LPS) - Atopic Asthma, Healthy | Phase 1 | Terminated | John Sundy | 17 | 2007-09-01 | 2013-07-16 |
| Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen Challenge House Dust Mite, Diluent - Atopic Asthma, Healthy | Phase 1 | Terminated | John Sundy | 40 | 2006-10-01 | 2013-07-16 |
| Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout Pegloticase - Gout | Phase 2 | Completed | John Sundy | 30 | 2004-12-01 | 2014-10-03 |
| Nitric Oxide, LPS and the Pathogenesis of Asthma Phase II LPS endotoxin - Healthy | Phase 1 | Terminated | John Sundy | 70 | 2003-04-01 | 2013-07-16 |
| Role of TLR4 in Environmental Asthma Lipopolysaccharide endotoxin - Asthma | Phase 1 | Completed | John Sundy | 855 | 2001-09-01 | 2013-07-16 |
Asthma (3) · Gout (1) · Hypersensitivity (1)
Antigens, Dermatophagoides (1) · Influenza Vaccines (1) · Lipopolysaccharides (1) · Pegloticase (1) · Phenol (1) · trinitrophenyl-lipopolysaccharide (1)
United States (6)
John S Sundy, M.D., PhD. (2) · John C Sundy, M.D. PhD (1) · John S Sundy, M.D., PhD (1) · John S. Sundy, MD, PhD (1)